| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MBX Biosciences, Inc. | Director | Common Stock | 102,082 | $1,091,257 | $10.69 | 16 Sep 2024 | Direct |
| MBX Biosciences, Inc. | Director | Stock option (right to buy) | 16,000 | 05 Jun 2025 | Direct | ||
| MBX Biosciences, Inc. | Director | Series A Convertible Preferred Stock | 0 | 16 Sep 2024 | Direct | ||
| MBX Biosciences, Inc. | Director | Series B Convertible Preferred Stock | 0 | 16 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MBX | MBX Biosciences, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 08:04 |
| MBX | MBX Biosciences, Inc. | 16 Sep 2024 | 3 | $0 | 4 | Director | 17 Sep 2024, 20:11 |
| MBX | MBX Biosciences, Inc. | 12 Sep 2024 | 1 | $0 | 4 | Director | 13 Sep 2024, 17:02 |
| MBX | MBX Biosciences, Inc. | 12 Sep 2024 | 0 | $0 | 3 | Director | 12 Sep 2024, 19:23 |